19-[(beta-D-glucopyranosyl)oxy]-19-oxo-ent-labda-8(17),13-dien-16,15-olide - Names and Identifiers
Name | ent-Labda-8(17),13-dien-16,15-olid-19-oic acid glucosyl ester
|
Synonyms | ENT-LABDA-8(17),13-DIEN-16,15-OL 15-olid-19-oic acid glucosyl ester ent-Labda-8(17),13-dien-16,15-olid-19-oic acid glucosyl ester 19-[(β-D-glucopyranosyl)oxy]-19-oxo-ent-labda-8(17),13-dien-16,15-olide 19-[(beta-D-glucopyrasyl)oxy]-19-oxo-ent-labda-8(17),13-dien-16,15-olide 19-[(beta-D-glucopyranosyl)oxy]-19-oxo-ent-labda-8(17),13-dien-16,15-olide β-D-Glucopyranose, 1-[(1S,4aS,5R,8aR)-5-[2-(2,5-dihydro-2-oxo-3-furanyl)ethyl]decahydro-1,4a-dimethyl-6-methylene-1-naphthalenecarboxylate] beta-D-Glucopyranose 1-[(1S,4aS,5R,8aR)-5-[2-(2,5-dihydro-2-oxo-3-furanyl)ethyl]decahydro-1,4a-dimethyl-6-methylene-1-naphthalenecarboxylate]
|
CAS | 919120-78-8
|
19-[(beta-D-glucopyranosyl)oxy]-19-oxo-ent-labda-8(17),13-dien-16,15-olide - Physico-chemical Properties
Molecular Formula | C26H38O9
|
Molar Mass | 494.58 |
Density | 1.32±0.1 g/cm3(Predicted) |
Boling Point | 667.6±55.0 °C(Predicted) |
Specific Rotation(α) | ?25 (c, 0.2 in MeOH) |
pKa | 12.51±0.70(Predicted) |
Storage Condition | 2-8℃ |
19-[(beta-D-glucopyranosyl)oxy]-19-oxo-ent-labda-8(17),13-dien-16,15-olide - Introduction
ent-Labda-8(17),13-dien-16,15-olid-19-oic acid glucosyl ester(ent-Labda-8(17),13-dien-16,15-olid-19-oic acid glucosyl ester) is a natural compound, it is a combination of ent-labdane compounds and gluconate. The following is a description of some of the properties, uses, preparation and safety information of the compound:
Nature:
-Appearance: A solid, may be white or yellow crystalline powder
-Molecular formula: C30H48O7
-Molecular weight: 520.70g/mol
-Melting Point: No Data
-Solubility: Soluble in some organic solvents, such as methanol, dimethyl sulfoxide, etc.
Use:
ent-Labda-8(17),13-dien-16,15-olid-19-oic acid glucosyl ester has anti-inflammatory, antioxidant and antibacterial biological activities. It has potential application value in the fields of pharmacy, health care products and cosmetics. For example, it can be used as a pharmaceutical material for the treatment of inflammation-related diseases.
Method:
ent-Labda-8(17),13-dien-16,15-olid-19-oic acid glucosyl ester can be obtained from natural plants or artificial synthesis. A common method is to extract ent-labdane compounds from plants and then combine them with gluconate esters through chemical synthesis.
Safety Information:
The specific toxicity and safety studies of ent-Labda-8(17),13-dien-16,15-olid-19-oic acid glucosyl ester are rarely reported. Therefore, its safety evaluation needs further research and testing. During handling and use, care should be taken to comply with laboratory safety procedures and take appropriate personal protective measures, such as wearing gloves and glasses. If it is necessary to use this compound, it is recommended to operate under the guidance of professionals. Do not directly inhale or ingest the compound, avoid contact with skin and eyes. In the case of accidental exposure or inhalation, medical assistance should be sought immediately.
Last Update:2024-04-09 21:54:55